AAAhmed Al-Mousawi

Ahmed Al-Mousawi

*This is an algorithmically generated author record based on publicly available information.

Ahmed Al-Mousawi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Fabio Nicoli

    Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary Hospital Newcastle NHS Foundation Trust, Newcastle upon Tyne, UK

    2 shared publications
  • Ahmed Al-Mousawi

    Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary Hospital NHS Foundation Trust, Newcastle upon Tyne, UK

    1 shared publication
  • Alberto Balzani

    Department of Plastic and Reconstructive Surgery, University of Rome “Tor Vergata”, Rome, Italy

    1 shared publication
  • Alberto Balzani

    Department of Plastic and Reconstructive Surgery, University of Rome "Tor Vergata", Rome, Italy

    1 shared publication
  • Chunxiao Cui

    Division of Reconstructive Microsurgery, Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine (China), 639 Zhi Zao Ju Road, Shanghai, 200011, China

    1 shared publication
  • Chunxiao Cui

    Shanghai Children’s Medical Center, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique

    by Ke Li, Fabio Nicoli, Chunxiao Cui, Wen Jing Xi, Ahmed Al-Mousawi, Zheng Zhang, Alberto Balzani, Lindsay Neill, Roberto Sorge, Yun Tong, et al.

    Hypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel and minimally invasive treatment alternative for scar modulation and volume reduction. A prospective cohort study was performed involving 21 patients with hypertrophic scars (HS) (n = 9) and keloids (n = 12) resulting from various aetiology. Patients were treated with one to three treatment sessions. Comprehensive evaluations were performed using the Vancouver Scar Scale, Doppler ultrasound, Cutometer, Mexameter and PeriCam PSI. Scar thickness was reduced by an average of 0.308 ± 0.138 cm (p < 0.001). In particular the two subgroups showed a significant 27.7% and 28.2% reduction in scar thickness of HS and Keloids, respectively. Scar firmness showed a significant improvement of 1.2% (p < 0.05) for HS, though for keloids this was 0.4% (p = 0.26). Keloids had a significant reduction in pigmentation at 21.3%. Blood perfusion had a significant reduction of 29.6% in HS and 22.7% in Keloids. Overall VSS total score improvement of 42% in the HS and at 37.9% in the Keloid subgroup. No adverse events such as hypo/hyperpigmentation, skin infection, or recurrence were reported. This study shows that the intralesional 1470 nm bare-fibre diode laser significantly improved hypertrophic and keloid scars based on both subjective and objective analyses and supports this type of laser therapy as a safe and effective minimally-invasive treatment option.


  • Open Access

    The 1470 nm diode laser with an intralesional fiber device: a proposed solution for the treatment of inflamed and infected keloids

    by Ke Li, Fabio Nicoli, Wen Jing Xi, Zheng Zhang, Chunxiao Cui, Ahmed Al-Mousawi, Alberto Balzani, Yun Tong, Yixin Zhang

    Background: Keloids are the result of abnormal wound healing and often are subject to infections and recurrent inflammation. We present a study conducted with a 1470 nm diode laser using an intralesional optical fiber device for the treatment of inflamed keloid scars. We evaluate its efficacy as a novel alternative method to decrease keloid infection and inflammation. Methods: The patients who underwent 1470 nm laser treatment from February 2016 to February 2018 at the plastic and reconstructive surgery department of the Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University with keloid accompanying serious local infection and fester were included. Patients took curative effect evaluation before and 1 year after the treatment. The test items included infection frequency in each year; pain, by visual analogue scale (VAS); itch, using VAS; quality of life (QOL), using QOL scale; and blood supply, using PeriCam PSI. Results: A total of 19 patients (mean age 35.21 years, range 11–66) with history of inflamed keloids with episodes of infection or abscess were enrolled. Patients underwent to a 1470 nm laser therapy for average of 1.16 times. After treatment, infection frequency and blood supply in keloids were reduced (p < 0.001). Pain, itching, and QOL were improved (p < 0.001). Conclusion: The present study shows that 1470 nm fiber laser treatment could improve inflamed keloids fairly well by decreasing inflammation, and a relative stabilization of collagen composition. Therefore, it is an effective minimally invasive scar therapy, but further studies are essential to confirm the present results.